Global Rounds: United States

Muhammad Shahzeb Khan; Ahmed Mustafa Rashid; Joseph S. Ross

doi:10.1161/circulationaha.125.074990

Global Rounds: United States

M Muhammad Shahzeb Khan (Baylor Scott & White Research Institute, Baylor Scott & White Health, Dallas, TX (M.S.K.. A.M.R.).) A Ahmed Mustafa Rashid (Baylor Scott & White Research Institute, Baylor Scott & White Health, Dallas, TX (M.S.K.. A.M.R.).) J Joseph S. Ross (Section of General Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT)

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Circulation

Volume / Issue Vol. 152, Issue 18

Published November 04, 2025

Pages 1265-1267

DOI 10.1161/circulationaha.125.074990

ISSN 0009-7322

Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (3)

M

Muhammad Shahzeb Khan

Baylor Scott & White Research Institute, Baylor Scott & White Health, Dallas, TX (M.S.K.. A.M.R.).

A

Ahmed Mustafa Rashid

Baylor Scott & White Research Institute, Baylor Scott & White Health, Dallas, TX (M.S.K.. A.M.R.).

J

Joseph S. Ross

Section of General Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT

Global Rounds: United States

Article Details

Journal Info

Authors (3)

Related Articles from this Journal

Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations

Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”

Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>

ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction

Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”